共 50 条
- [8] Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer [J]. ONCOLOGIST, 2021, 26 (08): : 694 - 700
- [10] Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 457 - 466